Principal Scientist

Andy Diep is a synthetic organic chemist with 13+ years within biotechnology and pharmaceutical industries. Hands-on experience in CMC drug development from pre-clinical through full-scale manufacturing. His areas of expertise span from medicinal chemistry to process development, manufacturing, project management, and regulatory. His previous experience includes working as a medicinal / process chemist at Forest Laboratories. He has been involved in the development of several key drugs such as Bystolic®, Viibryd®, Teflaro®, GK1-399, Dutogliptin, and is co-inventor of 15 issued patents. Dr. Diep received a B.S in chemistry from LSU, a Ph.D. in synthetic organic chemistry from Montana State University, and an MBA in business management from Kaplan University.